ANDAORALCAPSULE
Approved
Nov 2016
Lifecycle
Post-LOE
Competitive Pressure
30/100
Data completeness
3/8 — Basic
OMEPRAZOLE AND SODIUM BICARBONATE (omeprazole and sodium bicarbonate) by Aurobindo Pharma is proton pump inhibitors [moa]. Approved for proton pump inhibitor [epc]. First approved in 2016.
Drug data last refreshed Yesterday
Mechanism of Action
Proton Pump Inhibitors
Pharmacologic Class:
Proton Pump Inhibitor
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Worked on OMEPRAZOLE AND SODIUM BICARBONATE at Aurobindo Pharma? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.